<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Diabetes</journal-id><journal-id journal-id-type="iso-abbrev">JMIR Diabetes</journal-id><journal-id journal-id-type="pmc-domain-id">3559</journal-id><journal-id journal-id-type="pmc-domain">jmirdiab</journal-id><journal-id journal-id-type="publisher-id">diabetes</journal-id><journal-title-group><journal-title>JMIR Diabetes</journal-title></journal-title-group><issn pub-type="epub">2371-4379</issn><publisher><publisher-name>JMIR Publications Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11555900</article-id><article-id pub-id-type="pmcid-ver">PMC11555900.1</article-id><article-id pub-id-type="pmcaid">11555900</article-id><article-id pub-id-type="pmcaiid">11555900</article-id><article-id pub-id-type="pmid">39499162</article-id><article-id pub-id-type="doi">10.2196/53083</article-id><article-id pub-id-type="publisher-id">53083</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="primary-section"><subject>Telemedicine for Diabetes</subject></subj-group><subj-group subj-group-type="secondary-section"><subject>Aging with Chronic Disease</subject></subj-group><subj-group subj-group-type="secondary-section"><subject>Telehealth and Telemonitoring</subject></subj-group><subj-group subj-group-type="secondary-section"><subject>Sensors for Glucose Monitoring and Diabetes Management</subject></subj-group><subj-group subj-group-type="secondary-section"><subject>Chronic Foot Ulcer and Wounds</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Remote Foot Temperature Monitoring Among Veterans: Large Observational Study of Noncompliance and Its Correlates</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4247-8286</contrib-id><name name-style="western"><surname>Littman</surname><given-names initials="AJ">Alyson J</given-names></name><degrees>MPH, PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor1" ref-type="corresp"/><email>alyson.littman@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4013-716X</contrib-id><name name-style="western"><surname>Timmons</surname><given-names initials="AK">Andrew K</given-names></name><degrees>MS</degrees><xref rid="aff1" ref-type="aff">1</xref><email>andrew.timmons2@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8771-5468</contrib-id><name name-style="western"><surname>Korpak</surname><given-names initials="A">Anna</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><email>anna.korpak@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1095-7837</contrib-id><name name-style="western"><surname>Chan</surname><given-names initials="KCG">Kwun C G</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff4" ref-type="aff">4</xref><email>kcgchan@uw.edu</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5206-897X</contrib-id><name name-style="western"><surname>Jones</surname><given-names initials="KT">Kenneth T</given-names></name><degrees>PhD</degrees><xref rid="aff5" ref-type="aff">5</xref><email>kenneth.jones8@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0001-8541-1815</contrib-id><name name-style="western"><surname>Shirley</surname><given-names initials="S">Suzanne</given-names></name><degrees>LCSW</degrees><xref rid="aff6" ref-type="aff">6</xref><email>suzanne.shirley@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0008-2785-2605</contrib-id><name name-style="western"><surname>Nordrum</surname><given-names initials="K">Kyle</given-names></name><degrees>DPT</degrees><xref rid="aff6" ref-type="aff">6</xref><email>kyle.nordrum@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0009-5688-4355</contrib-id><name name-style="western"><surname>Robbins</surname><given-names initials="J">Jeffrey</given-names></name><degrees>DPM</degrees><xref rid="aff7" ref-type="aff">7</xref><email>jeffrey.robbins@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8876-7059</contrib-id><name name-style="western"><surname>Masadeh</surname><given-names initials="S">Suhail</given-names></name><degrees>DPM</degrees><xref rid="aff8" ref-type="aff">8</xref><email>suhail.masadeh@va.gov</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0681-6866</contrib-id><name name-style="western"><surname>Moy</surname><given-names initials="E">Ernest</given-names></name><degrees>MD</degrees><xref rid="aff5" ref-type="aff">5</xref><email>ernest.moy@va.gov</email></contrib><aff id="aff1"><label>1</label><institution content-type="department">Seattle ERIC</institution>, <institution>VA Puget Sound Health Care System</institution>, <addr-line>1660 S Columbian Way, S-152E</addr-line>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">WA</addr-line>, <addr-line>98108</addr-line>, <country>United States</country>, <phone>1 206-277-4182</phone></aff><aff id="aff2"><label>2</label><institution content-type="department">Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care</institution>, <institution>VA Puget Sound Health Care System</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">WA</addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Department of Epidemiology</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">WA</addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="department">Department of Biostatistics</institution>, <institution>University of Washington</institution>, <addr-line content-type="city">Seattle</addr-line>, <addr-line content-type="state">WA</addr-line>, <country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="department">VA Office of Health Equity</institution>, <institution>Department of Veterans Affairs</institution>, <addr-line content-type="city">Washington</addr-line>, <addr-line content-type="state">DC</addr-line>, <country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="department">VHA Innovation Ecosystem</institution>, <institution>Department of Veterans Affairs</institution>, <addr-line content-type="city">Washington</addr-line>, <addr-line content-type="state">DC</addr-line>, <country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="department">Podiatry Program Office, Department of Veterans Affairs Central Office</institution>, <institution>Specialty Care Services</institution>, <addr-line content-type="city">Washington</addr-line>, <addr-line content-type="state">DC</addr-line>, <country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="department">Department of Surgery, Division of Podiatry</institution>, <institution>Cincinnati Veteran Affairs Medical Center</institution>, <addr-line content-type="city">Cincinnati</addr-line>, <addr-line content-type="state">OH</addr-line>, <country>United States</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mizokami-Stout</surname><given-names initials="K">Kara</given-names></name></contrib></contrib-group><author-notes><corresp id="cor1">Alyson JLittmanMPH, PhD, Seattle ERIC, VA Puget Sound Health Care System, 1660 S Columbian Way, S-152E, Seattle, WA, 98108, United States, <phone>1 206-277-4182</phone>; <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="alyson.littman@va.gov">alyson.littman@va.gov</email></corresp><fn fn-type="COI-statement"><p>None declared.</p></fn></author-notes><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>5</day><month>11</month><year>2024</year></pub-date><volume>9</volume><issue-id pub-id-type="pmc-issue-id">455033</issue-id><elocation-id>e53083</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2023</year></date><date date-type="rev-recd"><day>10</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>12</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-13 10:25:16.430"><day>13</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Alyson J Littman, Andrew K Timmons, Anna Korpak, Kwun C G Chan, Kenneth T Jones, Suzanne Shirley, Kyle Nordrum, Jeffrey Robbins, Suhail Masadeh, Ernest Moy. Originally published in JMIR Diabetes (https://diabetes.jmir.org)</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Diabetes, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://diabetes.jmir.org/">https://diabetes.jmir.org/</ext-link>, as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="diabetes-v9-e53083.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="diabetes-v9-e53083.pdf"/><abstract><title>Abstract</title><sec><title>Background</title><p>In-home remote foot temperature monitoring (RTM) holds promise as a method to reduce foot ulceration in high-risk patients with diabetes. Few studies have evaluated adherence to this method or evaluated the factors associated with noncompliance.</p></sec><sec><title>Objective</title><p>The aims of this study were to estimate noncompliance in patients who were enrolled in RTM nationwide across Department of Veterans Affairs (VA) and to evaluate characteristics associated with noncompliance.</p></sec><sec><title>Methods</title><p>We conducted an observational study including 1137 patients in the VA who were enrolled in RTM between January 2019 and June 2021, with follow-up through October 2021. Patient information was obtained from the VA&#8217;s electronic health record and RTM use was obtained from the company. Noncompliance was defined as using the mat &lt;2 days per week for &#8805;4 of the 12 months of follow-up. Using a multivariable model, we calculated odds ratios (ORs) and 95% CIs for associations between various factors and noncompliance and compared using Akaike information criterion statistics, a measure of model fit.</p></sec><sec><title>Results</title><p>The sample was predominantly male (n=1125, 98.94%) ; 21.1% (n=230) were Black and 75.7% (n=825) were White. Overall, 37.6% (428/1137) of patients were classified as noncompliant. In the multivariable model, an intermediate area deprivation index was statistically significantly and inversely associated with noncompliance (area deprivation index 50&#8208;74 vs 1&#8208;24; OR 0.56, 95% CI 0.35-0.89); factors significantly and positively associated with noncompliance included recent history of osteomyelitis (OR 1.44, 95% CI 1.06-1.97), Gagne comorbidity index score &#8805;4 (vs &#8804;0; OR 1.81, 95% CI 1.15-2.83), telehealth encounters (28+ vs &lt;6; OR 1.70, 95% CI 1.02-2.84), hemoglobin A<sub>1c</sub>&#8805;10 (vs &lt;5.7; OR 2.67, 95% CI 1.27-5.58), and current smoking (OR 2.06, 95% CI 1.32-3.20). Based on Akaike information criterion differences, the strongest factors associated with noncompliance were behavioral factors (poor glucose control [as measured by hemoglobin A<sub>1c</sub>] and smoking), and to a lesser extent, factors such as a recent history of osteomyelitis and an elevated Gagne comorbidity index, indicating a high comorbidity burden.</p></sec><sec><title>Conclusions</title><p>To reduce the risk of ulcer recurrence and amputation, proactively providing additional support for self-monitoring to patients with characteristics identified in this study (poor glucose control, current smoking, high comorbidity burden) may be helpful. Furthermore, research is needed to better understand barriers to use, and whether the addition of design features, reminders, or incentives may reduce noncompliance and the risk of foot ulcers.</p></sec></abstract><kwd-group kwd-group-type="author-keywords"><title>Keywords</title><kwd>diabetes</kwd><kwd>self-monitoring</kwd><kwd>ulceration</kwd><kwd>compliance</kwd><kwd>foot temperature monitoring</kwd><kwd>SmartMat</kwd><kwd>adherence</kwd><kwd>remote</kwd><kwd>monitoring</kwd><kwd>non-compliance</kwd><kwd>foot</kwd><kwd>ulcer</kwd><kwd>diabetic</kwd><kwd>veteran</kwd><kwd>observational</kwd><kwd>health record</kwd><kwd>EHR</kwd><kwd>noncompliance</kwd><kwd>electronic health record</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Diabetic foot ulcers are common, debilitating, and costly diabetes complications. Over 10 percent of US adults [<xref rid="R1" ref-type="bibr">1</xref>] and nearly a quarter of veterans enrolled in Veterans Health Administration (VHA) have diabetes [<xref rid="R2" ref-type="bibr">2</xref>]. In patients with diabetes, lifetime risk of ulceration is estimated to be 14% [<xref rid="R3" ref-type="bibr">3</xref>]. Ulcerations negatively impact mobility, mental health, and quality of life, and have high recurrence rates. Nearly two-thirds of patients have a recurrence within 5 years of ulcer healing [<xref rid="R4" ref-type="bibr">4</xref>]. Loss of pain sensitivity, foot deformity, and peripheral artery disease place individuals at high initial and subsequent risk of ulceration; these conditions do not resolve after healing.</p><p>Five systematic reviews and meta-analyses [<xref rid="R5" ref-type="bibr">5-9</xref>] have been conducted that each included the same 4 or 5 [<xref rid="R10" ref-type="bibr">10-14</xref>] randomized controlled trials of foot temperature monitoring. While there were slightly different analytic approaches in each meta-analysis, all estimated a substantially lower risk of ulceration in the groups assigned to monitor plantar foot temperatures compared to the usual care groups (meta-analysis odds ratios [ORs] or relative risks ranged from 0.37 [<xref rid="R7" ref-type="bibr">7</xref>] to 0.53 [<xref rid="R8" ref-type="bibr">8</xref>]). Based on this research, several clinical organizations have endorsed foot temperature monitoring [<xref rid="R15" ref-type="bibr">15-17</xref>], but it is rarely practiced because measuring temperatures on multiple parts of feet daily and then calculating differences between the feet is time consuming and burdensome. New technologies, including temperature sensing mats, have eliminated much of the burden, and made foot temperature monitoring easier [<xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref>].</p><p>In 2019, the VHA, the largest integrated health care system in the United States, began national implementation of remote foot temperature monitoring (RTM) using SmartMats. The VHA Innovation Ecosystem launched the Initiative to End Diabetic Limb Loss [<xref rid="R20" ref-type="bibr">20</xref>] in partnership with the VHA Podiatry Service, Office of Health Equity and Office of Connected Care to design new care models that incorporated emerging technologies such as the SmartMat in early detection of diabetic foot ulcers.</p><p>We are aware of a single study that published data on compliance with use of the SmartMat [<xref rid="R21" ref-type="bibr">21</xref>]. This study included 132 people with diabetes and a prior diabetic foot ulcer who were recruited from 7 outpatient sites in the United States. During 34 weeks of follow-up, patients used the device 5.0 days per week on average (SD not reported) and 86% of patients used the SmartMat &#8805;3 times per week [<xref rid="R21" ref-type="bibr">21</xref>]. Data on characteristics associated with use were not reported.</p><p>Understanding compliance outside of a study is valuable to assess the real-world potential for effectiveness. Additionally, identifying which patients might be less likely to comply with RTM recommendations could be helpful to identify barriers and determine which patients might benefit from additional support to improve compliance. Thus, the aims of this study were to estimate noncompliance in patients who were enrolled in RTM nationwide across VHA between 2019 and 2021 and to evaluate characteristics associated with noncompliance.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2-1"><title>Study Data</title><p>Demographic, geographic, medical, and use data came from the corporate data warehouse (CDW). Race and ethnicity are determined based on self report. During this study&#8217;s period, when a patient was enrolled in RTM, their Department of Veterans Affairs (VA) provider placed an order for the device through the Prosthetics Department. As the company making the devices only had 1 product, we were able to determine enrollment in RTM based on the Data Universal Numbering System number (DUN &amp; Bradstreet). The company provided information on the average number of times per week that patients used the mat each calendar month from January 2019 until October 2021.</p></sec><sec id="s2-2"><title>Study Population</title><p>We included individuals who were enrolled in RTM in VA between January 2019 and June 2021 (as identified in the CDW) and for whom we were also able to obtain SmartMat use data. Of those enrolled in January 2019 or later (n=1675), we were able to link 1641 individuals to other data in the CDW. We excluded 504 people with less than 12 months of follow-up, leaving 1137. Due to how the variables were constructed, individuals for whom we could not determine a home facility (n=123) were included in most analyses, but were missing for area deprivation index (ADI), VA district or region, and facility complexity.</p></sec><sec id="s2-3"><title>RTM in VA</title><p>The device under investigation is a daily-use telemedicine foot temperature monitoring SmartMat made by Podimetrics. Patients with a high risk of ulceration (mainly due to a history of foot ulceration; lower limb, foot, or toe amputation; or Charcot foot) are eligible for RTM (Kyle Nordrum, DPT, personal communication). The device is ready to use without any configuration or set-up. A temperature scan takes 20 seconds, and the temperature data are transmitted to the cloud using an embedded cellular component. All scans are timestamped, allowing for objective measures of use. The software detects &#8220;hot spots,&#8221; defined as asymmetries of &#8805;2.2&#730;C between the same region on the left and right foot or different regions on the same foot. Temperature asymmetries that persist for at least 2 days are predictive of ulceration [<xref rid="R21" ref-type="bibr">21</xref>]. When hot spots are detected, either clinical support staff from the company or the VA provider follows-up with the patient to evaluate risk factors and make recommendations about actions to take. Patients are also called if they fail to use the mat for several days in a row to assess reasons for nonuse and encourage re-engagement.</p></sec><sec id="s2-4"><title>Definition of Noncompliance</title><p>While daily use is recommended, using the device at least 2 times per week is thought to be sufficient for the detection of hot spots (Jon Bloom, MD, personal communication). As we had a relatively long follow-up (12 mo), we defined noncompliance as using the mat less than 2 times per week for at least a quarter of the months under observation. Specifically, patients were considered noncompliant if they used the mat less than 2 days per week for 4 or more months out of 12.</p></sec><sec id="s2-5"><title>Compliance Correlates or Predictors</title><p>We evaluated demographic, geographic, clinical, and facility factors, as well as health care use as potential correlates of nonadherence. Details about the data sources, definitions, and categories are included in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><title> Data definitions, categories, and sources.</title></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" rowspan="1" colspan="1">Domain, variable</td><td valign="bottom" rowspan="1" colspan="1">Categories</td><td valign="bottom" rowspan="1" colspan="1">Data sources, timing, and other details</td></tr></thead><tbody><tr><td valign="top" colspan="2" rowspan="1">
<bold>Demographics</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Sex</td><td valign="top" rowspan="1" colspan="1">Male or female</td><td valign="top" rowspan="1" colspan="1">CDW<xref rid="T1_FN2" ref-type="table-fn"><sup>a</sup></xref>; assumed to be sex assigned at birth</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Race</td><td valign="top" rowspan="1" colspan="1">American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Pacific Islander, White, or more than 1 race</td><td valign="top" rowspan="1" colspan="1">CDW, based on self report</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Hispanic or Latinx ethnicity</td><td valign="top" rowspan="1" colspan="1">Yes or no</td><td valign="top" rowspan="1" colspan="1">CDW, based on self report</td></tr><tr><td valign="top" colspan="2" rowspan="1">
<bold>Geographic access</bold>
</td><td valign="top" rowspan="1" colspan="1">CDW; drive distance and drive time used the most recent data (FY14-FY19<xref rid="T1_FN6" ref-type="table-fn"><sup>b</sup></xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Drive time to primary care</td><td valign="top" rowspan="1" colspan="1">&lt;30 minutes or &#8805;30 minutes</td><td valign="top" rowspan="1" colspan="1">Estimated drive time between the coordinates of the primary care facility nearest to the veteran&#8217;s home and the veteran&#8217;s home address.</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Drive time to specialty care</td><td valign="top" rowspan="1" colspan="1">&lt;60 minutes or &#8805;60 minutes</td><td valign="top" rowspan="1" colspan="1">Estimated drive time (network distance) between the coordinates of the specialty care facility nearest to the veteran&#8217;s home and the veteran&#8217;s home address.</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Rurality</td><td valign="top" rowspan="1" colspan="1">Urban, rural, or highly rural</td><td valign="top" rowspan="1" colspan="1">Determined using RUCA<xref rid="T1_FN3" ref-type="table-fn"><sup>c</sup></xref> codes, which are based on zip code approximations. RUCA codes of 10=highly rural; RUCA codes of 1 or 1.1=urban. All other codes were considered rural [<xref rid="R22" ref-type="bibr">22</xref>].</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;VA<xref rid="T1_FN4" ref-type="table-fn"><sup>d</sup></xref> districts</td><td valign="top" rowspan="1" colspan="1">Continental, Midwest, North Atlantic, Pacific, and Southeast</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" colspan="2" rowspan="1">
<bold>Area level factors</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Area Deprivation Index (ADI)</td><td valign="top" rowspan="1" colspan="1">Quartiles&#8212;lower ADI<xref rid="T1_FN5" ref-type="table-fn"><sup>e</sup></xref> indicates <italic toggle="yes">less</italic> deprivation</td><td valign="top" rowspan="1" colspan="1">The ADI is a measure of socioeconomic resources and well-being that includes factors for income, education, employment, and housing quality. The ADI has been adapted and validated to the Census Block Group [<xref rid="R23" ref-type="bibr">23</xref>] and allows for rankings of neighborhoods by socioeconomic disadvantage at the national level.</td></tr><tr><td valign="top" colspan="2" rowspan="1">
<bold>Clinical characteristics</bold>
</td><td valign="top" rowspan="1" colspan="1">CDW; ascertained in the 2 years prior to baseline</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Other conditions: Chronic kidney disease or end stage renal disease, diabetes, and depression</td><td valign="top" rowspan="1" colspan="1">Yes or no</td><td valign="top" rowspan="1" colspan="1">At least 2 diagnosis codes or 1 procedure code.</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Gagne comorbidity index</td><td valign="top" rowspan="1" colspan="1">&lt;0, 1&#8208;2, 3&#8208;4, &gt;4</td><td valign="top" rowspan="1" colspan="1">Measure of comorbidity burden. Higher scores indicate more comorbidities [<xref rid="R24" ref-type="bibr">24</xref>].</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Body mass index</td><td valign="top" rowspan="1" colspan="1">&lt;18.5, 18.5&#8208;24.9, 25&#8208;29.9, 30&#8208;39.9, &#8805;40 kg/m<sup>2</sup></td><td valign="top" rowspan="1" colspan="1">Weight and height measured closest to and prior to first scan.</td></tr><tr><td valign="top" colspan="2" rowspan="1">
<bold>Facility characteristics</bold>
</td><td valign="top" rowspan="1" colspan="1">CDW</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Facility complexity</td><td valign="top" rowspan="1" colspan="1">1a (most complex), 1b, 1c, 2, 3 (low complexity)</td><td valign="top" rowspan="1" colspan="1">Determined based on a model that considers clinical programs and patient risk levels, as well as research and teaching. The model is reviewed and updated with current data every 3 years.</td></tr><tr><td valign="top" colspan="2" rowspan="1">
<bold>Use</bold>
</td><td valign="top" rowspan="1" colspan="1">CDW; ascertained in the 2 years prior to baseline</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Inpatient stays</td><td valign="top" align="char" rowspan="1" colspan="1">0, 1+</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;Telehealth encounters</td><td valign="top" rowspan="1" colspan="1">Quartiles</td><td valign="top" rowspan="1" colspan="1">Determined by stop codes, and includes visits that were designated as telephone, video, &#8220;tele,&#8221; or virtual</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN2" fn-type="other"><label>a</label><p>CDW: corporate data warehouse.</p></fn><fn id="T1_FN6" fn-type="other"><label>b</label><p>FY: fiscal year.</p></fn><fn id="T1_FN3" fn-type="other"><label>c</label><p>RUCA: Rural Urban Commuting Area.</p></fn><fn id="T1_FN4" fn-type="other"><label>d</label><p>VA: Department of Veterans Affairs.</p></fn><fn id="T1_FN5" fn-type="other"><label>e</label><p>ADI: area deprivation index.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-6"><title>Statistical Analyses</title><p>We calculated the percentage of patients who were noncompliant, with 95% CIs. To evaluate associations between characteristics and noncompliance, we estimated OR and corresponding 95% CIs using a logistic regression model that included all covariates. The Akaike information criterion (AIC) was used to assess contributions of each covariate and groups of covariates to model fit along with a likelihood ratio test for a model that excluded the covariate or group of covariates [<xref rid="R25" ref-type="bibr">25</xref>]. AIC helps to quantify how well a model fits the data it was generated from relative to other models fit on the same data. AIC penalizes models that use more parameters to reduce the potential for overfitting. Lower AIC scores are considered evidence of better model fit.</p><p>Missing data were recovered using multiple imputation by chained equations using all covariates and the outcome and results displayed are from pooling the 20 imputed datasets [<xref rid="R26" ref-type="bibr">26-28</xref>]. Generalized variance inflation factors [<xref rid="R29" ref-type="bibr">29</xref>] for each of the covariates were calculated to assess correlation between covariates, and the impact it may have had on regression results. A variance inflation factor of 4 or more was used as evidence of substantial collinearity [<xref rid="R30" ref-type="bibr">30</xref>]; there was no evidence of substantial collinearity.</p><p>We conducted several sensitivity analyses. First, because there is no empirical basis for our definition of noncompliance [<xref rid="R31" ref-type="bibr">31</xref>], and some prior studies have used a higher cutoff, we conducted analyses using different cut points of minimum days per week on average (2 and 3) and months in the past 12 (11, 9, and 6) for defining noncompliance. Second, we graphically explored the association between hospitalization and separately, amputation, on SmartMat use by examining use in the 6 months prior to, and the 6 months after a hospitalization or amputation (separately). In these analyses, we categorized days per week into 4 categories: no use, &lt;2 days per week, 2 to &lt;5 days per week, and 5&#8208;7 days per week. We also graphed use over time in those with a hospitalization or amputation (separately) relative to those who had neither a hospitalization nor an amputation.</p></sec><sec id="s2-7"><title>Ethical Considerations</title><p>This program evaluation qualified as a nonresearch quality improvement activity conducted under the authority of VHA operations. It complies with the VHA definition of &#8220;non-research operations activities&#8221; outlined in section 5a of the 2019 <italic toggle="yes">VHA Program Guide 1200.21: VHA Operations Activities That May Constitute Research</italic>, meeting both specified conditions: (1) the evaluation was designed and implemented for internal VHA purposes and (2) not designed to produce information to expand the knowledge base of a scientific discipline.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>The sample was predominantly male (n=1125, 98.94%); 21.1% (n=230) were Black and 75.7% (n=825) were White (<xref rid="T2" ref-type="table">Tables2 </xref><xref rid="T3" ref-type="table"> 3</xref>). Just over half (n=595, 53.8%) of the patients were married. Nearly half (n=525, 46.2%) of the patients were aged between 70 and 79 years and 96.9% (n=1102) had diabetes. In the 2 years prior to baseline, 82.0% (n=932) had a diabetic foot ulcer, 40.4% (n=459) had osteomyelitis, 41.6% (n=473) had chronic kidney disease or end stage renal disease, 30.7% (n=349) had depression, and 53.3% (n=606) were hospitalized. Over a third (n=409, 36.0%) had a Gagne comorbidity of 4 or greater and 59.8% (n=660) had a BMI&gt;30 kg/m<sup>2</sup>. About two-thirds of patients had poorly controlled diabetes based on a hemoglobin A<sub>1c</sub> greater than or equal to 7.0, including 7% (n=80) with a hemoglobin A<sub>1c</sub> greater than or equal to 10. Further, 31.2% (n=181) of patients were current smokers, though smoking status was missing for nearly half of the participants. Lastly, 74.9% (n=851) of the patients lived in urban areas and less than 20% (n=143, 12.6%) lived more than 30 minutes&#8217; drive time from primary care or 60 minutes&#8217; drive time from specialty care (n=182, 16%). Most of the patients came from the Midwest (n=361, 35.6%) or the Pacific region (n=335, 33.0%), while less than 5% (n=48) of the patients were from the Southeast. <xref rid="SAP1" ref-type="supplementary-material">Multimedia Appendix 1</xref> compares those included in analyses to those who were excluded because of insufficient follow-up. Briefly, the individuals with insufficient follow-up who were excluded from analyses had fewer ulcer risk factors, were predominantly from the Continental region, and were more likely to live in rural areas where they had longer drive times to primary and specialty care.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2.</label><caption><title>Demographic, socioeconomic, and health characteristics of patients enrolled in remote foot temperature monitoring in the Department of Veterans Affairs between January 2019 and June 2021 (N=1137).<xref rid="T2_FN2" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="T2_FN3" ref-type="table-fn"><sup>b</sup></xref><sup>,</sup><xref rid="T2_FN4" ref-type="table-fn"><sup>c</sup></xref><sup>,</sup><xref rid="T2_FN5" ref-type="table-fn"><sup>d</sup></xref></title></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="3" valign="top" rowspan="1">Characteristic</td><td valign="top" rowspan="1" colspan="1">Patients, n (%)</td></tr></thead><tbody><tr><td colspan="3" valign="top" rowspan="1">
<bold>Demographic or socioeconomic</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Sex</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Female</td><td valign="top" rowspan="1" colspan="1">12 (1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Male</td><td valign="top" rowspan="1" colspan="1">1125 (98.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Race</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">American Indian or Alaska Native</td><td valign="top" rowspan="1" colspan="1">11 (1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Asian</td><td valign="top" rowspan="1" colspan="1">1 (&lt;1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Black</td><td valign="top" rowspan="1" colspan="1">230 (21.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">More than one race</td><td valign="top" rowspan="1" colspan="1">10 (1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Native Hawaiian or Other Pacific Islander</td><td valign="top" rowspan="1" colspan="1">13 (1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">White</td><td valign="top" rowspan="1" colspan="1">825 (75.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Ethnicity</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Hispanic or Latino</td><td valign="top" rowspan="1" colspan="1">77 (7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Not Hispanic or Latino</td><td valign="top" rowspan="1" colspan="1">1038 (93.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Marital status</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Married</td><td valign="top" rowspan="1" colspan="1">595 (53.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Separated or divorced</td><td valign="top" rowspan="1" colspan="1">317 (27.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Single</td><td valign="top" rowspan="1" colspan="1">136 (12.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Widowed</td><td valign="top" rowspan="1" colspan="1">58 (5)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Area deprivation index (national rank)<xref rid="T2_FN1" ref-type="table-fn"><sup>e</sup></xref></bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1&#8208;24</td><td valign="top" rowspan="1" colspan="1">232 (22.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">25&#8208;49</td><td valign="top" rowspan="1" colspan="1">281 (27.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">50&#8208;74</td><td valign="top" rowspan="1" colspan="1">256 (25.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">75+</td><td valign="top" rowspan="1" colspan="1">245 (24.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Unknown</td><td valign="top" rowspan="1" colspan="1">123 (10.8)</td></tr><tr><td colspan="3" valign="top" rowspan="1">
<bold>Health or comorbidities</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Age (years)</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;50</td><td valign="top" rowspan="1" colspan="1">17 (2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">50&#8208;59</td><td valign="top" rowspan="1" colspan="1">123 (10.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">60&#8208;69</td><td valign="top" rowspan="1" colspan="1">353 (31.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">70&#8208;79</td><td valign="top" rowspan="1" colspan="1">525 (46.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">80+</td><td valign="top" rowspan="1" colspan="1">119 (10.5)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Diabetes</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">35 (3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">1102 (96.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Nonhealing ulcer</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">205 (18.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">932 (82.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Osteomyelitis</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">678 (59.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">459 (40.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Chronic kidney disease or end stage kidney disease</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">664 (58.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">473 (41.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Lower extremity amputation</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Neither</td><td valign="top" rowspan="1" colspan="1">664 (58.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Partial foot</td><td valign="top" rowspan="1" colspan="1">213 (18.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Major lower limb</td><td valign="top" rowspan="1" colspan="1">260 (22.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Gagne comorbidity index</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&#8804;0</td><td valign="top" rowspan="1" colspan="1">319 (28.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1&#8208;2</td><td valign="top" rowspan="1" colspan="1">219 (19.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">3&#8208;4</td><td valign="top" rowspan="1" colspan="1">190 (16.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&gt;4</td><td valign="top" rowspan="1" colspan="1">409 (36.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Depression</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" rowspan="1" colspan="1">788 (69.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" rowspan="1" colspan="1">349 (30.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Body mass index (kg/m</bold>
<sup>
<bold>2</bold>
</sup>
<bold>)</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;18.5</td><td valign="top" rowspan="1" colspan="1">2 (&lt;1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">18.5&#8208;24.9</td><td valign="top" rowspan="1" colspan="1">136 (12.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">25&#8208;29.9</td><td valign="top" rowspan="1" colspan="1">305 (27.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">30&#8208;39.9</td><td valign="top" rowspan="1" colspan="1">547 (49.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">40+</td><td valign="top" rowspan="1" colspan="1">113 (10.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Inpatient visits</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">0</td><td valign="top" rowspan="1" colspan="1">531 (46.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1+</td><td valign="top" rowspan="1" colspan="1">606 (53.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Telehealth encounters</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;6</td><td valign="top" rowspan="1" colspan="1">141 (12.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">6&#8208;12</td><td valign="top" rowspan="1" colspan="1">234 (20.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">13&#8208;27</td><td valign="top" rowspan="1" colspan="1">361 (31.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">28+</td><td valign="top" rowspan="1" colspan="1">401 (35.3)</td></tr></tbody></table><table-wrap-foot><fn id="T2_FN2" fn-type="other"><label>a</label><p>Non-compliance defined as mat use of &lt;2 times per week for 4 or more of the 12 months of follow-up.</p></fn><fn id="T2_FN3" fn-type="other"><label>b</label><p>Categories may not summay not sum up to column total because of missing values.</p></fn><fn id="T2_FN4" fn-type="other"><label>c</label><p>Percent calculated among those with non-missing values.</p></fn><fn id="T2_FN5" fn-type="other"><label>d</label><p>Unknown category presented if &gt;5% of total sample.</p></fn><fn id="T2_FN1" fn-type="other"><label>e</label><p>Lower ADIarea deprivation index indicates less deprivation.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3.</label><caption><title>Behavioral, access to care, and practice patterns characteristics of patients enrolled in remote foot temperature monitoring in the Department of Veterans Affairs between January 2019 and June 2021 (N=1137).<xref rid="T3_FN1" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="T3_FN2" ref-type="table-fn"><sup>b</sup></xref><sup>,</sup><xref rid="T3_FN3" ref-type="table-fn"><sup>c</sup></xref><sup>,</sup><xref rid="T3_FN4" ref-type="table-fn"><sup>d</sup></xref></title></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="3" valign="top" rowspan="1">Characteristic</td><td valign="top" rowspan="1" colspan="1">Patients, n (%)</td></tr></thead><tbody><tr><td colspan="3" valign="top" rowspan="1">
<bold>Behavioral</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Hemoglobin A</bold>
<sub>
<bold>1c</bold>
</sub>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;5.7</td><td valign="top" align="char" rowspan="1" colspan="1">72 (6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">5.7&#8208;6.9</td><td valign="top" align="char" rowspan="1" colspan="1">298 (26.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">7&#8208;7.9</td><td valign="top" align="char" rowspan="1" colspan="1">318 (28.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">8&#8208;9.9</td><td valign="top" align="char" rowspan="1" colspan="1">315 (28.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">10+</td><td valign="top" align="char" rowspan="1" colspan="1">80 (7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No diabetes</td><td valign="top" align="char" rowspan="1" colspan="1">25 (2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Smoking status</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Current smoker</td><td valign="top" align="char" rowspan="1" colspan="1">181 (31.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Former smoker</td><td valign="top" align="char" rowspan="1" colspan="1">204 (35.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Never smoker</td><td valign="top" align="char" rowspan="1" colspan="1">196 (33.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Unknown</td><td valign="top" align="char" rowspan="1" colspan="1">556 (48.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Substance use disorder</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">905 (79.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">232 (20.4)</td></tr><tr><td colspan="3" valign="top" rowspan="1">
<bold>Access to care</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Rurality</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Rural or highly rural</td><td valign="top" align="char" rowspan="1" colspan="1">286 (25.2)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Urban</td><td valign="top" align="char" rowspan="1" colspan="1">851 (74.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Drive time (primary care)</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;30 min</td><td valign="top" align="char" rowspan="1" colspan="1">991 (87.4)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">30+ min</td><td valign="top" align="char" rowspan="1" colspan="1">143 (12.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Drive time (specialty care)</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;60 min</td><td valign="top" align="char" rowspan="1" colspan="1">952 (84.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">60+ min</td><td valign="top" align="char" rowspan="1" colspan="1">182 (16.0)</td></tr><tr><td colspan="3" valign="top" rowspan="1">
<bold>Practice patterns</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Department of Veterans Affairs district or region</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Continental</td><td valign="top" align="char" rowspan="1" colspan="1">131 (12.9)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Midwest</td><td valign="top" align="char" rowspan="1" colspan="1">361 (35.6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">North Atlantic</td><td valign="top" align="char" rowspan="1" colspan="1">139 (13.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Pacific</td><td valign="top" align="char" rowspan="1" colspan="1">335 (33.0)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Southeast</td><td valign="top" align="char" rowspan="1" colspan="1">48 (5)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Unknown</td><td valign="top" align="char" rowspan="1" colspan="1">123 (10.8)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Facility complexity</bold>
</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1a&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">433 (42.7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1b&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">315 (31.1)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1c&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">135 (13.3)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">2&#8212;medium complexity</td><td valign="top" align="char" rowspan="1" colspan="1">71 (7)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">3&#8212;low complexity</td><td valign="top" align="char" rowspan="1" colspan="1">60 (6)</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Unknown</td><td valign="top" align="char" rowspan="1" colspan="1">123 (10.8)</td></tr></tbody></table><table-wrap-foot><fn id="T3_FN1" fn-type="other"><label>a</label><p>Noncompliance defined as mat use of &lt;2 times per week for 4 or more of the 12 months of follow-up.</p></fn><fn id="T3_FN2" fn-type="other"><label>b</label><p>Categories may not sum up to column total because of missing values.</p></fn><fn id="T3_FN3" fn-type="other"><label>c</label><p>Percent calculated among those with nonmissing values.</p></fn><fn id="T3_FN4" fn-type="other"><label>d</label><p>Unknown category presented if &gt;5% of total sample.</p></fn></table-wrap-foot></table-wrap><p>Overall, 37.6% (428/1137) of patients were classified as noncompliant (<xref rid="T4" ref-type="table">Tables4</xref><xref rid="T6" ref-type="table">6</xref> and <xref rid="F1" ref-type="fig">Figure 1</xref>). Mat use declined over time; by month 12, over 30% of patients never used the mat in the prior month. In descriptive analyses, the factors associated with higher noncompliance (5 percentage points or more above the mean) included race other than Black or White (43% noncompliance), Hispanic or Latino ethnicity (48%), widowed (47%), ADI &lt;24 (47%), age &lt;60 (47% for those aged &lt;50 years and 44% for those aged 50&#8208;59 years), osteomyelitis (45%), major lower limb amputation (44%), Gagne comorbidity index &gt;4 (48%), depression (44%), BMI &lt;25 kg/m<sup>2</sup> (49%), inpatient visit in the 2 years before baseline (43%), more than 28 telehealth encounters (43%), hemoglobin A<sub>1c</sub> &#8805;10 (60%), current smoking (54%), substance use disorder (53%), living in the Pacific region (44%), and receiving care at a high-complexity facility (44%). The factors associated with <italic toggle="yes">lower</italic> noncompliance (5 percentage points or more below the mean) included being a female (33% noncompliance) and living in an area with an ADI between 50 and 74 (31%); <italic toggle="yes">not</italic> having a recent history of ulceration (32%), osteomyelitis (33%), or hospitalization (31%); and having a lower comorbidity index score (&#8804;0: 29% noncompliance; 1&#8208;2: 30% noncompliance); BMI &#8805;30 kg/m<sup>2</sup> (30&#8208;39.9 kg/m<sup>2</sup>: 33% noncompliance; &#8805;40 kg/m<sup>2</sup>: 30% noncompliance) fewer than 12 telehealth encounters (&lt;6: 28% noncompliance, 6&#8208;12: 31% noncompliance); and hemoglobin A<sub>1c</sub> between 7 and 7.9 (32% noncompliance). Lastly, noncompliance was lower among those from the Midwest (32%) and at low-complexity facilities (22%). In the multivariable model, compared to an ADI &lt;25, intermediate ADI was inversely associated with noncompliance (ADI 50&#8208;74: OR 0.56, 95% CI 0.35-0.89); associations for the other categories were not statistically significantly different from the lowest ADI category. Recent history of osteomyelitis (OR 1.44, 95% CI 1.06&#8208;1.97), Gagne comorbidity index score &#8805;4 (vs &#8804;0: OR 1.81, 95% CI 1.15-2.83), telehealth encounters (13&#8208;27 vs &lt;6: OR 1.65, 95% CI 1.01-2.70; 28+ vs &lt;6: OR 1.70, 95% CI 1.02-2.84), hemoglobin A<sub>1c</sub> &#8805;10 (vs &lt;5.7: OR 2.67, 95% CI 1.27-5.58), and current smoking (vs never smoking: OR 2.06, 95% CI 1.32-3.20) were statistically significantly and positively associated with noncompliance. Using AIC to help inform the contribution of different variables to model fit, behavioral factors (hemoglobin A<sub>1c</sub> and smoking), and to a lesser extent, health conditions or comorbidities (eg, osteomyelitis and Gagne comorbidity index) most contributed to model fit (<xref rid="T7" ref-type="table">Table 7</xref>). The results were not meaningfully different in the sensitivity analyses that used different cut points for minimum number of days per week and months in the past 12 to define noncompliance (data not presented).</p><table-wrap position="float" id="T4" orientation="portrait"><label>Table 4.</label><caption><title>Estimated associations<xref rid="T4_FN1" ref-type="table-fn"><sup>a</sup></xref> of demographic or socioeconomic characteristics with remote foot temperature monitoring noncompliance<xref rid="T4_FN2" ref-type="table-fn"><sup>b</sup></xref> within conceptual groups using multiply imputed data (N=1137).</title></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="2" valign="top" rowspan="1">Demographic or socioeconomic characteristics</td><td valign="top" rowspan="1" colspan="1">Noncompliant (%)</td><td valign="top" rowspan="1" colspan="1">95% CI</td><td valign="top" rowspan="1" colspan="1">Adjusted odds ratio</td><td valign="top" rowspan="1" colspan="1">95% CI</td></tr></thead><tbody><tr><td colspan="2" valign="top" rowspan="1">
<bold>Sex</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Female</td><td valign="top" align="char" rowspan="1" colspan="1">33</td><td valign="top" align="char" rowspan="1" colspan="1">14&#8208;61</td><td valign="top" align="char" rowspan="1" colspan="1">0.69</td><td valign="top" align="char" rowspan="1" colspan="1">0.18&#8208;2.65</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Male</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;41</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Race</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Black</td><td valign="top" align="char" rowspan="1" colspan="1">42</td><td valign="top" align="char" rowspan="1" colspan="1">36&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">1.34</td><td valign="top" align="char" rowspan="1" colspan="1">0.92&#8208;1.95</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Race other than Black or white</td><td valign="top" align="char" rowspan="1" colspan="1">43</td><td valign="top" align="char" rowspan="1" colspan="1">28&#8208;59</td><td valign="top" align="char" rowspan="1" colspan="1">1.23</td><td valign="top" align="char" rowspan="1" colspan="1">0.57&#8208;2.65</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">White</td><td valign="top" align="char" rowspan="1" colspan="1">36</td><td valign="top" align="char" rowspan="1" colspan="1">33&#8208;39</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Ethnicity</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Hispanic or Latino</td><td valign="top" align="char" rowspan="1" colspan="1">48</td><td valign="top" align="char" rowspan="1" colspan="1">37&#8208;59</td><td valign="top" align="char" rowspan="1" colspan="1">1.46</td><td valign="top" align="char" rowspan="1" colspan="1">0.86&#8208;2.47</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Not Hispanic or Latino</td><td valign="top" align="char" rowspan="1" colspan="1">37</td><td valign="top" align="char" rowspan="1" colspan="1">34&#8208;40</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Marital status</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Married</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;39</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Separated or divorced</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;46</td><td valign="top" align="char" rowspan="1" colspan="1">1.10</td><td valign="top" align="char" rowspan="1" colspan="1">0.79&#8208;1.52</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Single</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;48</td><td valign="top" align="char" rowspan="1" colspan="1">0.94</td><td valign="top" align="char" rowspan="1" colspan="1">0.60&#8208;1.46</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Widowed</td><td valign="top" align="char" rowspan="1" colspan="1">47</td><td valign="top" align="char" rowspan="1" colspan="1">34&#8208;59</td><td valign="top" align="char" rowspan="1" colspan="1">1.28</td><td valign="top" align="char" rowspan="1" colspan="1">0.69&#8208;2.38</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Area deprivation index national rank</bold>
<xref rid="T4_FN3" ref-type="table-fn">
<sup>
<bold>c</bold>
</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1&#8208;24</td><td valign="top" align="char" rowspan="1" colspan="1">47</td><td valign="top" align="char" rowspan="1" colspan="1">41&#8208;53</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">25&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">41</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;46</td><td valign="top" align="char" rowspan="1" colspan="1">0.77</td><td valign="top" align="char" rowspan="1" colspan="1">0.51&#8208;1.16</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">50&#8208;74</td><td valign="top" align="char" rowspan="1" colspan="1">31</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;37</td><td valign="top" align="char" rowspan="1" colspan="1">0.56</td><td valign="top" align="char" rowspan="1" colspan="1">0.35&#8208;0.89</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">75+</td><td valign="top" align="char" rowspan="1" colspan="1">37</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;43</td><td valign="top" align="char" rowspan="1" colspan="1">0.65</td><td valign="top" align="char" rowspan="1" colspan="1">0.39&#8208;1.08</td></tr></tbody></table><table-wrap-foot><fn id="T4_FN1" fn-type="other"><label>a</label><p>A single multivariable model was used to estimate adjusted odds ratios; each factor was adjusted for all of the other factors in the model.</p></fn><fn id="T4_FN2" fn-type="other"><label>b</label><p>Non-compliance defined by average weekly mat use of &lt;&lt;2 days per week for at least 4 of the 12 months of follow-up.</p></fn><fn id="T4_FN3" fn-type="other"><label>c</label><p>Lower ADIarea deprivation index indicates less deprivation.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T5" orientation="portrait"><label>Table 5.</label><caption><title>Estimated associations<xref rid="T5_FN1" ref-type="table-fn"><sup>a</sup></xref> of health characteristics with remote foot temperature monitoring noncompliance<xref rid="T5_FN2" ref-type="table-fn"><sup>b</sup></xref> within conceptual groups using multiply imputed data (N=1137).</title></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="2" valign="top" rowspan="1">Health or comorbidities characteristics</td><td valign="top" rowspan="1" colspan="1">Noncompliant (%)</td><td valign="top" rowspan="1" colspan="1">95% CI</td><td valign="top" rowspan="1" colspan="1">Adjusted odds ratio</td><td valign="top" rowspan="1" colspan="1">95% CI</td></tr></thead><tbody><tr><td colspan="2" valign="top" rowspan="1">
<bold>Age (years)</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;50</td><td valign="top" align="char" rowspan="1" colspan="1">47</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;69</td><td valign="top" align="char" rowspan="1" colspan="1">1.49</td><td valign="top" align="char" rowspan="1" colspan="1">0.49&#8208;4.48</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">50&#8208;59</td><td valign="top" align="char" rowspan="1" colspan="1">44</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;53</td><td valign="top" align="char" rowspan="1" colspan="1">1.19</td><td valign="top" align="char" rowspan="1" colspan="1">0.75&#8208;1.89</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">60&#8208;69</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">33&#8208;43</td><td valign="top" align="char" rowspan="1" colspan="1">0.86</td><td valign="top" align="char" rowspan="1" colspan="1">0.62&#8208;1.19</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">70&#8208;79</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;39</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">80+</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">1.48</td><td valign="top" align="char" rowspan="1" colspan="1">0.92&#8208;2.38</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Nonhealing ulcer</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">32</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;38</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">39</td><td valign="top" align="char" rowspan="1" colspan="1">36&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">1.02</td><td valign="top" align="char" rowspan="1" colspan="1">0.68&#8208;1.52</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Osteomyelitis</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">33</td><td valign="top" align="char" rowspan="1" colspan="1">29&#8208;36</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">45</td><td valign="top" align="char" rowspan="1" colspan="1">40&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">1.44</td><td valign="top" align="char" rowspan="1" colspan="1">1.06&#8208;1.97</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Chronic kidney disease or end stage renal disease</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">34&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">41</td><td valign="top" align="char" rowspan="1" colspan="1">36&#8208;45</td><td valign="top" align="char" rowspan="1" colspan="1">0.89</td><td valign="top" align="char" rowspan="1" colspan="1">0.65&#8208;1.23</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Lower extremity amputation</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Neither</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;38</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Partial foot</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;45</td><td valign="top" align="char" rowspan="1" colspan="1">1.01</td><td valign="top" align="char" rowspan="1" colspan="1">0.70&#8208;1.46</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Major lower limb</td><td valign="top" align="char" rowspan="1" colspan="1">44</td><td valign="top" align="char" rowspan="1" colspan="1">38&#8208;50</td><td valign="top" align="char" rowspan="1" colspan="1">1.11</td><td valign="top" align="char" rowspan="1" colspan="1">0.77&#8208;1.60</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Gagne index</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&#8804;0</td><td valign="top" align="char" rowspan="1" colspan="1">29</td><td valign="top" align="char" rowspan="1" colspan="1">24&#8208;34</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1&#8208;2</td><td valign="top" align="char" rowspan="1" colspan="1">30</td><td valign="top" align="char" rowspan="1" colspan="1">24&#8208;36</td><td valign="top" align="char" rowspan="1" colspan="1">0.78</td><td valign="top" align="char" rowspan="1" colspan="1">0.50&#8208;1.21</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">3&#8208;4</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">33&#8208;47</td><td valign="top" align="char" rowspan="1" colspan="1">1.37</td><td valign="top" align="char" rowspan="1" colspan="1">0.86&#8208;2.18</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&gt;4</td><td valign="top" align="char" rowspan="1" colspan="1">48</td><td valign="top" align="char" rowspan="1" colspan="1">43&#8208;53</td><td valign="top" align="char" rowspan="1" colspan="1">1.81</td><td valign="top" align="char" rowspan="1" colspan="1">1.15&#8208;2.83</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Depression</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;38</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">44</td><td valign="top" align="char" rowspan="1" colspan="1">38&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">1.19</td><td valign="top" align="char" rowspan="1" colspan="1">0.87&#8208;1.62</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Body mass index (kg/m</bold>
<sup>
<bold>2</bold>
</sup>
<bold>)</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;25</td><td valign="top" align="char" rowspan="1" colspan="1">49</td><td valign="top" align="char" rowspan="1" colspan="1">41&#8208;58</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">25&#8208;29.9</td><td valign="top" align="char" rowspan="1" colspan="1">42</td><td valign="top" align="char" rowspan="1" colspan="1">37&#8208;48</td><td valign="top" align="char" rowspan="1" colspan="1">0.89</td><td valign="top" align="char" rowspan="1" colspan="1">0.57&#8208;1.40</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">30&#8208;39.9</td><td valign="top" align="char" rowspan="1" colspan="1">33</td><td valign="top" align="char" rowspan="1" colspan="1">29&#8208;37</td><td valign="top" align="char" rowspan="1" colspan="1">0.70</td><td valign="top" align="char" rowspan="1" colspan="1">0.45&#8208;1.08</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">40+</td><td valign="top" align="char" rowspan="1" colspan="1">30</td><td valign="top" align="char" rowspan="1" colspan="1">22&#8208;39</td><td valign="top" align="char" rowspan="1" colspan="1">0.73</td><td valign="top" align="char" rowspan="1" colspan="1">0.40&#8208;1.33</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Inpatient visits</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">0</td><td valign="top" align="char" rowspan="1" colspan="1">31</td><td valign="top" align="char" rowspan="1" colspan="1">27&#8208;35</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">1+</td><td valign="top" align="char" rowspan="1" colspan="1">43</td><td valign="top" align="char" rowspan="1" colspan="1">40&#8208;47</td><td valign="top" align="char" rowspan="1" colspan="1">0.89</td><td valign="top" align="char" rowspan="1" colspan="1">0.62&#8208;1.28</td></tr><tr><td colspan="2" valign="top" rowspan="1">
<bold>Telehealth encounters</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;6</td><td valign="top" align="char" rowspan="1" colspan="1">28</td><td valign="top" align="char" rowspan="1" colspan="1">21&#8208;36</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">6&#8208;12</td><td valign="top" align="char" rowspan="1" colspan="1">31</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;37</td><td valign="top" align="char" rowspan="1" colspan="1">1.19</td><td valign="top" align="char" rowspan="1" colspan="1">0.71&#8208;1.99</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">13&#8208;27</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;45</td><td valign="top" align="char" rowspan="1" colspan="1">1.65</td><td valign="top" align="char" rowspan="1" colspan="1">1.01&#8208;2.70</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">28+</td><td valign="top" align="char" rowspan="1" colspan="1">43</td><td valign="top" align="char" rowspan="1" colspan="1">38&#8208;48</td><td valign="top" align="char" rowspan="1" colspan="1">1.70</td><td valign="top" align="char" rowspan="1" colspan="1">1.02&#8208;2.84</td></tr></tbody></table><table-wrap-foot><fn id="T5_FN1" fn-type="other"><label>a</label><p>A single multivariable model was used to estimate adjusted odds ratios; each factor was adjusted for all of the other factors in the model.</p></fn><fn id="T5_FN2" fn-type="other"><label>b</label><p>Noncompliance defined by average weekly mat use of &lt;2 days per week for at least 4 of the 12 months of follow-up.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T6" orientation="portrait"><label>Table 6.</label><caption><title>Estimated associations<xref rid="T6_FN1" ref-type="table-fn"><sup>a</sup></xref> of behavioral, access to care, and practice pattern characteristics with remote foot temperature monitoring noncompliance<xref rid="T6_FN2" ref-type="table-fn"><sup>b</sup></xref> within conceptual groups using multiply imputed data (N=1137).</title></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="3" valign="top" rowspan="1">Characteristic</td><td valign="top" rowspan="1" colspan="1">Noncompliant (%)</td><td valign="top" rowspan="1" colspan="1">95% CI</td><td valign="top" rowspan="1" colspan="1">Adjusted odds ratio</td><td valign="top" rowspan="1" colspan="1">95% CI</td></tr></thead><tbody><tr><td colspan="3" valign="top" rowspan="1">
<bold>Behavioral</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Hemoglobin A</bold>
<sub>
<bold>1c</bold>
</sub>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;5.7</td><td valign="top" align="char" rowspan="1" colspan="1">42</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;53</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">5.7&#8208;6.9</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">30&#8208;40</td><td valign="top" align="char" rowspan="1" colspan="1">0.90</td><td valign="top" align="char" rowspan="1" colspan="1">0.50&#8208;1.62</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">7&#8208;7.9</td><td valign="top" align="char" rowspan="1" colspan="1">32</td><td valign="top" align="char" rowspan="1" colspan="1">27&#8208;38</td><td valign="top" align="char" rowspan="1" colspan="1">0.89</td><td valign="top" align="char" rowspan="1" colspan="1">0.49&#8208;1.61</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">8&#8208;9.9</td><td valign="top" align="char" rowspan="1" colspan="1">39</td><td valign="top" align="char" rowspan="1" colspan="1">34&#8208;45</td><td valign="top" align="char" rowspan="1" colspan="1">1.14</td><td valign="top" align="char" rowspan="1" colspan="1">0.63&#8208;2.05</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">10+</td><td valign="top" align="char" rowspan="1" colspan="1">60</td><td valign="top" align="char" rowspan="1" colspan="1">49&#8208;70</td><td valign="top" align="char" rowspan="1" colspan="1">2.67</td><td valign="top" align="char" rowspan="1" colspan="1">1.27&#8208;5.58</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No diabetes</td><td valign="top" align="char" rowspan="1" colspan="1">34</td><td valign="top" align="char" rowspan="1" colspan="1">21&#8208;51</td><td valign="top" align="char" rowspan="1" colspan="1">0.96</td><td valign="top" align="char" rowspan="1" colspan="1">0.37&#8208;2.44</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Smoking status</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Current smoker</td><td valign="top" align="char" rowspan="1" colspan="1">54</td><td valign="top" align="char" rowspan="1" colspan="1">47&#8208;61</td><td valign="top" align="char" rowspan="1" colspan="1">2.06</td><td valign="top" align="char" rowspan="1" colspan="1">1.32&#8208;3.20</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Former smoker</td><td valign="top" align="char" rowspan="1" colspan="1">32</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;39</td><td valign="top" align="char" rowspan="1" colspan="1">0.96</td><td valign="top" align="char" rowspan="1" colspan="1">0.62&#8208;1.47</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Never smoker</td><td valign="top" align="char" rowspan="1" colspan="1">35</td><td valign="top" align="char" rowspan="1" colspan="1">29&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Substance use disorder</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">No</td><td valign="top" align="char" rowspan="1" colspan="1">34</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;37</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Yes</td><td valign="top" align="char" rowspan="1" colspan="1">53</td><td valign="top" align="char" rowspan="1" colspan="1">47-60</td><td valign="top" align="char" rowspan="1" colspan="1">1.33</td><td valign="top" align="char" rowspan="1" colspan="1">0.90&#8208;1.97</td></tr><tr><td colspan="3" valign="top" rowspan="1">
<bold>Access to care</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Rurality</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Highly rural or rural</td><td valign="top" align="char" rowspan="1" colspan="1">36</td><td valign="top" align="char" rowspan="1" colspan="1">31&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">1.10</td><td valign="top" align="char" rowspan="1" colspan="1">0.73&#8208;1.64</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Urban</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;41</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Drive time primary care</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;30 min</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;41</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">30+ min</td><td valign="top" align="char" rowspan="1" colspan="1">34</td><td valign="top" align="char" rowspan="1" colspan="1">27&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">0.90</td><td valign="top" align="char" rowspan="1" colspan="1">0.55&#8208;1.49</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Drive time specialty care</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">&lt;60 min</td><td valign="top" align="char" rowspan="1" colspan="1">37</td><td valign="top" align="char" rowspan="1" colspan="1">34&#8208;41</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" align="char" rowspan="1" colspan="1">60+ min</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;46</td><td valign="top" align="char" rowspan="1" colspan="1">1.04</td><td valign="top" align="char" rowspan="1" colspan="1">0.69&#8208;1.58</td></tr><tr><td colspan="3" valign="top" rowspan="1">
<bold>Practice patterns</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Department of Veterans Affairs district or region</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Continental</td><td valign="top" align="char" rowspan="1" colspan="1">38</td><td valign="top" align="char" rowspan="1" colspan="1">30&#8208;47</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Midwest</td><td valign="top" align="char" rowspan="1" colspan="1">32</td><td valign="top" align="char" rowspan="1" colspan="1">27&#8208;37</td><td valign="top" align="char" rowspan="1" colspan="1">0.90</td><td valign="top" align="char" rowspan="1" colspan="1">0.54&#8208;1.49</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">North Atlantic</td><td valign="top" align="char" rowspan="1" colspan="1">42</td><td valign="top" align="char" rowspan="1" colspan="1">35&#8208;51</td><td valign="top" align="char" rowspan="1" colspan="1">1.46</td><td valign="top" align="char" rowspan="1" colspan="1">0.82&#8208;2.58</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Pacific</td><td valign="top" align="char" rowspan="1" colspan="1">44</td><td valign="top" align="char" rowspan="1" colspan="1">39&#8208;50</td><td valign="top" align="char" rowspan="1" colspan="1">1.22</td><td valign="top" align="char" rowspan="1" colspan="1">0.71&#8208;2.10</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">Southeast</td><td valign="top" align="char" rowspan="1" colspan="1">40</td><td valign="top" align="char" rowspan="1" colspan="1">27&#8208;54</td><td valign="top" align="char" rowspan="1" colspan="1">1.94</td><td valign="top" align="char" rowspan="1" colspan="1">0.84&#8208;4.49</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td colspan="2" valign="top" rowspan="1">
<bold>Facility complexity</bold>
</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1a&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">44</td><td valign="top" align="char" rowspan="1" colspan="1">39&#8208;49</td><td valign="top" align="char" rowspan="1" colspan="1">1.00</td><td valign="top" rowspan="1" colspan="1">Reference</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1b&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">37</td><td valign="top" align="char" rowspan="1" colspan="1">32&#8208;43</td><td valign="top" align="char" rowspan="1" colspan="1">0.89</td><td valign="top" align="char" rowspan="1" colspan="1">0.56&#8208;1.40</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1c&#8212;high complexity</td><td valign="top" align="char" rowspan="1" colspan="1">34</td><td valign="top" align="char" rowspan="1" colspan="1">26&#8208;42</td><td valign="top" align="char" rowspan="1" colspan="1">0.88</td><td valign="top" align="char" rowspan="1" colspan="1">0.50&#8208;1.56</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">2&#8212;medium complexity</td><td valign="top" align="char" rowspan="1" colspan="1">34</td><td valign="top" align="char" rowspan="1" colspan="1">24&#8208;45</td><td valign="top" align="char" rowspan="1" colspan="1">0.80</td><td valign="top" align="char" rowspan="1" colspan="1">0.41&#8208;1.55</td></tr><tr><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">3&#8212;low complexity</td><td valign="top" align="char" rowspan="1" colspan="1">22</td><td valign="top" align="char" rowspan="1" colspan="1">13&#8208;34</td><td valign="top" align="char" rowspan="1" colspan="1">0.50</td><td valign="top" align="char" rowspan="1" colspan="1">0.23&#8208;1.06</td></tr></tbody></table><table-wrap-foot><fn id="T6_FN1" fn-type="other"><label>a</label><p>A single multivariable model was used to estimate adjusted odds ratios; each factor was adjusted for all of the other factors in the model.</p></fn><fn id="T6_FN2" fn-type="other"><label>b</label><p>Noncompliance defined by average weekly mat use of &lt;2 days per week for at least 4 of the 12 months of follow-up.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1.</label><caption><title> Average days per week remote temperature monitoring was used. Note that the group marked &#8220;0&#8221; is &gt;0 but less than 1. Individuals who did not use the mat at all in the month are represented by the absence of any bars.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="diabetes-v9-e53083-g001.jpg"/></fig><table-wrap position="float" id="T7" orientation="portrait"><label>Table 7.</label><caption><title>Summary of AIC<xref rid="T7_FN2" ref-type="table-fn"><sup>a</sup></xref> for conceptual groups and variables for association with noncompliance<xref rid="T7_FN1" ref-type="table-fn"><sup>b</sup></xref>.</title></caption><table frame="hsides" rules="groups"><thead><tr><td valign="bottom" rowspan="1" colspan="1">Conceptual group</td><td valign="bottom" rowspan="1" colspan="1">AIC</td><td valign="bottom" rowspan="1" colspan="1">AIC difference versus saturated model</td><td valign="bottom" rowspan="1" colspan="1">Likelihood ratio test <italic toggle="yes">P</italic> value<xref rid="T7_FN5" ref-type="table-fn"><sup>c</sup></xref></td></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">
<bold>Saturated model</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">1444</td><td align="left" valign="top" rowspan="1" colspan="1">Reference</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;<xref rid="T7_FN6" ref-type="table-fn"><sup>d</sup></xref></td></tr><tr><td valign="top" rowspan="1" colspan="1">
<bold>&#8195;Demographics</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">1437</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;7</td><td align="left" valign="top" rowspan="1" colspan="1">.30</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Sex</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.57</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Race</td><td align="left" valign="top" rowspan="1" colspan="1">1443</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;1</td><td align="left" valign="top" rowspan="1" colspan="1">.30</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Hispanic or Latinx ethnicity</td><td align="left" valign="top" rowspan="1" colspan="1">1444</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Marital status</td><td align="left" valign="top" rowspan="1" colspan="1">1439</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;5</td><td align="left" valign="top" rowspan="1" colspan="1">.78</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Area deprivation index</td><td align="left" valign="top" rowspan="1" colspan="1">1445</td><td align="left" valign="top" rowspan="1" colspan="1">+1</td><td align="left" valign="top" rowspan="1" colspan="1">.11</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;<bold>Health conditions or comorbidities</bold></td><td align="left" valign="top" rowspan="1" colspan="1">1461</td><td align="left" valign="top" rowspan="1" colspan="1">+17</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Age</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.23</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Ulcer</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.93</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Osteomyelitis</td><td align="left" valign="top" rowspan="1" colspan="1">1447</td><td align="left" valign="top" rowspan="1" colspan="1">+3</td><td align="left" valign="top" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Chronic kidney disease or end stage renal Disease</td><td align="left" valign="top" rowspan="1" colspan="1">1443</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;1</td><td align="left" valign="top" rowspan="1" colspan="1">.48</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Lower extremity amputation</td><td align="left" valign="top" rowspan="1" colspan="1">1440</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;4</td><td align="left" valign="top" rowspan="1" colspan="1">.84</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Gagne comorbidity index</td><td align="left" valign="top" rowspan="1" colspan="1">1454</td><td align="left" valign="top" rowspan="1" colspan="1">+10</td><td align="left" valign="top" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Depression</td><td align="left" valign="top" rowspan="1" colspan="1">1443</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;1</td><td align="left" valign="top" rowspan="1" colspan="1">.29</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Body mass index</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.28</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Inpatient visits</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.55</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Telehealth encounters</td><td align="left" valign="top" rowspan="1" colspan="1">1445</td><td align="left" valign="top" rowspan="1" colspan="1">+1</td><td align="left" valign="top" rowspan="1" colspan="1">.10</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;<bold>Behavioral</bold></td><td align="left" valign="top" rowspan="1" colspan="1">1473</td><td align="left" valign="top" rowspan="1" colspan="1">+29</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Hemoglobin A<sub>1c</sub></td><td align="left" valign="top" rowspan="1" colspan="1">1452</td><td align="left" valign="top" rowspan="1" colspan="1">+8</td><td align="left" valign="top" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Smoking</td><td align="left" valign="top" rowspan="1" colspan="1">1460</td><td align="left" valign="top" rowspan="1" colspan="1">+16</td><td align="left" valign="top" rowspan="1" colspan="1">.007</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Substance use disorder</td><td align="left" valign="top" rowspan="1" colspan="1">1444</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">.11</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;<bold>Access to care</bold></td><td align="left" valign="top" rowspan="1" colspan="1">1438</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;6</td><td align="left" valign="top" rowspan="1" colspan="1">.95</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Rurality</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.65</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;30+ min to primary care</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.67</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;60+ min to specialty care</td><td align="left" valign="top" rowspan="1" colspan="1">1442</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;2</td><td align="left" valign="top" rowspan="1" colspan="1">.86</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;<bold>Practice patterns</bold></td><td align="left" valign="top" rowspan="1" colspan="1">1443</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;1</td><td align="left" valign="top" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;District</td><td align="left" valign="top" rowspan="1" colspan="1">1445</td><td align="left" valign="top" rowspan="1" colspan="1">+1</td><td align="left" valign="top" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" rowspan="1" colspan="1">&#8195;&#8195;Facility complexity</td><td align="left" valign="top" rowspan="1" colspan="1">1441</td><td align="left" valign="top" rowspan="1" colspan="1">&#8722;3</td><td align="left" valign="top" rowspan="1" colspan="1">.46</td></tr></tbody></table><table-wrap-foot><fn id="T7_FN2" fn-type="other"><label>a</label><p>AIC: Akaike information criterion.</p></fn><fn id="T7_FN1" fn-type="other"><label>b</label><p>Larger AICAkaike information criterion difference vs.versus saturated model indicate more substantial contribution to the model fit.</p></fn><fn id="T7_FN5" fn-type="other"><label>c</label><p><italic toggle="yes">P</italic> values were calculated using a modification for multiply imputed data [<xref rid="R25" ref-type="bibr">25</xref>].</p></fn><fn id="T7_FN6" fn-type="other"><label>d</label><p>Not applicable.</p></fn></table-wrap-foot></table-wrap><p>When considering changes in use around the time of a hospitalization or amputation, we found that the fraction of people with 5&#8208;7 days per week of SmartMat use decreased, while the proportion of those with no SmartMat use increased in the month of the hospitalization or amputation (<xref rid="SAP2" ref-type="supplementary-material">MultimediaAppendices 2 </xref><xref rid="SAP3" ref-type="supplementary-material"> 3</xref>). The proportion with <italic toggle="yes">no</italic> SmartMat use increased slightly in the 6 months after the hospitalization or amputation (<xref rid="SAP4" ref-type="supplementary-material">MultimediaAppendices 4 </xref><xref rid="SAP5" ref-type="supplementary-material"> 5</xref>). Specifically, there was a larger increase in the proportion of patients with no use (and decrease in the proportion of patients with 5&#8208;7 d of use) in the month concurrent with a hospitalization or amputation as well as in the 6 months after, compared to the reference group of patients with no hospitalization or amputation during follow-up.</p></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>Even though the requirements of monitoring are minimal (20 s per day to obtain a scan), nearly 4 in 10 patients did not use the SmartMat at least 2 days per week for at least 75% of the months under observation. Based on AIC differences, the strongest factors associated with noncompliance were behavioral factors (poor glucose control [as measured by hemoglobin A<sub>1c</sub>] and smoking), and to a lesser extent, factors such as a recent history of osteomyelitis and an elevated Gagne comorbidity index, indicating a high comorbidity burden. Patients who are unable to manage their blood glucose levels or quit smoking, as well as those with osteomyelitis and numerous chronic comorbidities may also have challenges regularly using a home temperature monitoring device. Noncompliance was also higher among those who had a hospitalization or amputation. Although some results were different in descriptive analyses (eg, BMI and ADI) or statistically significant (eg, ADI) in our multivariable model, the absence of large AIC differences indicated that they did not contribute importantly to model fit and therefore may not be important factors for compliance. Additional research that replicates these findings and that can help us understand reasons for noncompliance in patients would be helpful to inform future interventions.</p><p>We are only aware of a single study [<xref rid="R21" ref-type="bibr">21</xref>] that evaluated compliance with a SmartMat for foot temperature monitoring, and that study found lower noncompliance using a more stringent definition. Unlike our study, the Frykberg et al [<xref rid="R21" ref-type="bibr">21</xref>] study excluded days during which a participant had a contraindication to using the mat (eg, for an open plantar wound) and considered those who did not use the mat for &gt;28 consecutive days as lost to follow-up (18.6% of the sample) [<xref rid="R21" ref-type="bibr">21</xref>]. As our sensitivity analyses indicated a reduction in use following a hospitalization or amputation, differences in use between the prior study and ours may be partly because we did not exclude any days. In any case, noncompliance in this study is similar to prior studies of foot temperature monitoring involving handheld thermometers. For example, in a trial of 151 people randomized to daily foot temperature monitoring using a handheld thermometer, 62% of participants measured foot temperatures at least 70% of days (equivalent to 38% noncompliance) [<xref rid="R14" ref-type="bibr">14</xref>]. Likewise, a study of daily temperature monitoring in Peru observed 60% compliance when treating those who did not return logbooks as nonadherent (vs adherence of 87% when leaving them out of the analysis, equivalent to 40% and 13% noncompliance) [<xref rid="R32" ref-type="bibr">32</xref>]. Estimates for foot temperature monitoring are also similar to general adherence to a variety of self-management activities in people with diabetes observed in meta-analyses [<xref rid="R33" ref-type="bibr">33</xref>]. In summary, even though RTM is a relatively low burden intervention, noncompliance rates are strikingly similar despite different definitions of adherence and different activity or intervention burdens, suggesting that factors other than time burden likely impact compliance.</p><p>The Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) [<xref rid="R34" ref-type="bibr">34</xref>] is a helpful framework for understanding why individuals accept and use technology and may help to understand factors impacting compliance with RTM. UTAUT2 outlines how 7 constructs influence consumers&#8217; intention to use a technology: (1) performance expectancy (does it help?), which is analogous to relative advantage in the diffusion of innovation literature [<xref rid="R35" ref-type="bibr">35</xref>] and perceived usefulness in the technology acceptance model [<xref rid="R36" ref-type="bibr">36</xref>], (2) effort expectancy (how easy is it to use?), (3) facilitating conditions (are there resources available to support use?), (4) social influence (do those close to the individual support their use of the technology?), (5) hedonic motivation (is it fun?), (6) price value (is it worth it financially?), and (7) habit (does it become a habit?).</p><p>Because we lack data from patients&#8217; perspectives, it is unclear whether patients perceived a benefit, especially those who did not have any hot spots, or had many hot spots. Unlike a scale or a blood pressure monitoring device, which provides direct feedback with each use, and a sense of accomplishment for those who are losing weight or lowering their blood pressure, patients were not routinely provided direct feedback. They were called if they did not use the mat, or if temperature asymmetries were detected. If perceived benefit is low, use may decrease over time. Even though the apparent time burden is low, there may be steps (such as removing socks and shoes) that may be challenging and prevent people from using the mat more regularly. Given that an annual SmartMat subscription includes access to company personnel to answer questions, the third construct from the UTAUT2, facilitating conditions, may be high. As social influence is known to be important in diabetes management [<xref rid="R37" ref-type="bibr">37</xref>], social influence may be an important factor for this technology. Unfortunately, we had no direct measures of social influence, and marital status (a poor proxy) was not associated with compliance, which is understandable because marital status does not provide a direct measure of whether someone has a positive social influence. RTM is intended for disease management and was not designed to be fun, so hedonic motivation may be low. Gamification (eg, points and badges for streaks or other goals) could make it more fun and might improve compliance [<xref rid="R38" ref-type="bibr">38</xref>]. Price value is likely low since VA provides the SmartMat free of charge to patients. Future studies that collect self-report information from patients, including patient interviews, could help elucidate the extent to which factors in the model facilitate use.</p></sec><sec id="s4-2"><title>Strengths and Limitations</title><p>A major strength of our study was its large size and ability to examine associations between various characteristics and SmartMat noncompliance. A potential limitation is that we did not have data on each day&#8217;s use, but instead an average number of days per week per month of follow-up. Though less precise, this level of detail is informative to understand trends. Third, there are no standard definitions of adherence or noncompliance, and our definition was different from the 1 used in a prior study [<xref rid="R21" ref-type="bibr">21</xref>], though it was based on expert opinion. Fourth, we lacked information on factors not readily available in the medical record such as patient preferences, perceived benefits, beliefs, attitudes, social support, and environmental factors that may have impacted use of the mats. This information would be useful to collect in future studies. Finally, because our sample included VA patients, individuals were primarily older White males, so results may not generalize to more diverse samples. Future research, particularly randomized trials testing different approaches to increase compliance (eg, gamification, incentives, patient and caregiver education, motivational interviewing, and reminders or alerts) in different patient populations, will be valuable to informing how to make technologies such as these more impactful.</p></sec><sec id="s4-3"><title>Conclusion</title><p>Our study found that a large fraction of patients did not use the SmartMat as directed, and thus they would be unlikely to benefit from it. Testing approaches to proactively provide additional support for self-monitoring to patients with poor glucose control, current smoking, or high comorbidity burden (factors associated with high noncompliance) is an important area of future research. Future research should also seek to understand patients&#8217; perspectives on their experience with SmartMats and why they may have routinely used, rarely used, or stopped using the mat. Reducing the risk of ulcer recurrence and amputation could have enormous benefits for individual patients and lower health care costs. Thus, ensuring that patients effectively employ tools to reduce the risk of ulcer recurrence is paramount.</p></sec></sec><sec sec-type="supplementary-material"><title>supplementary material</title><supplementary-material id="SAP1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.2196/53083</object-id><label>Multimedia Appendix 1</label><caption><title>Patient characteristics by study exclusion (N=1641).</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diabetes-v9-e53083-s001.docx" xlink:title="DOCX File, 24 KB" id="d67e3260" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SAP2" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.2196/53083</object-id><label>Multimedia Appendix 2</label><caption><title>Average days per week remote temperature monitoring was used among patients with a hospitalization during follow-up (n=477). Note that month 0 represents the month of their hospitalization and negative numbers on the x axis are months prior to their hospitalization and positive numbers are months after.</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diabetes-v9-e53083-s002.png" xlink:title="PNG File, 28 KB" id="d67e3267" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SAP3" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.2196/53083</object-id><label>Multimedia Appendix 3</label><caption><title>Average days per week remote temperature monitoring was used among patients with an amputation during follow-up (n=97). Note that month 0 represents the month of their amputation and negative numbers on the x axis are months prior to their amputation and positive numbers are months after.</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diabetes-v9-e53083-s003.png" xlink:title="PNG File, 27 KB" id="d67e3274" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SAP4" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.2196/53083</object-id><label>Multimedia Appendix 4</label><caption><title>Average days per week remote temperature monitoring was used among patients with a hospitalization during follow-up (n=477) compared to a reference group includes those who did not have a hospitalization or amputation during follow-up.</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diabetes-v9-e53083-s004.png" xlink:title="PNG File, 54 KB" id="d67e3281" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SAP5" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.2196/53083</object-id><label>Multimedia Appendix 5</label><caption><title>Average days per week remote temperature monitoring was used among patients with an amputation during follow-up (n=97) compared to a reference group that includes those who did not have a hospitalization or amputation during follow-up.</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diabetes-v9-e53083-s005.png" xlink:title="PNG File, 43 KB" id="d67e3288" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>The views expressed in this paper are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.</p></ack><notes><def-list><title>Abbreviations</title><def-item><term>ADI</term><def><p>area deprivation index</p></def></def-item><def-item><term>AIC</term><def><p>Akaike information criterion</p></def></def-item><def-item><term>CDW</term><def><p>corporate data warehouse</p></def></def-item><def-item><term>FY</term><def><p>fiscal year</p></def></def-item><def-item><term>OR</term><def><p>odds ratio</p></def></def-item><def-item><term>RTM</term><def><p>remote foot temperature monitoring</p></def></def-item><def-item><term>RUCA</term><def><p>Rural Urban Commuting Area</p></def></def-item><def-item><term>UTAUT2</term><def><p>Unified Theory of Acceptance and Use of Technology 2</p></def></def-item><def-item><term>VA</term><def><p>Department of Veterans Affairs</p></def></def-item><def-item><term>VHA</term><def><p>Veterans Health Administration</p></def></def-item></def-list></notes><ref-list><title>References</title><ref id="R1"><label>1.</label><element-citation publication-type="webpage"><article-title>National diabetes statistics report</article-title><source>Centers for Disease Control and Prevention</source><year>2017</year><comment>URL</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/diabetes/php/data-research/index.html" ext-link-type="uri">https://www.cdc.gov/diabetes/php/data-research/index.html</ext-link></element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="webpage"><article-title>Diabetes mellitus</article-title><source>Federal Practitioner</source><comment>URL</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fedprac-digital.com/federalpractitioner/data_trends_2017?pg=20#pg20" ext-link-type="uri">https://www.fedprac-digital.com/federalpractitioner/data_trends_2017?pg=20#pg20</ext-link><comment>Accessed</comment><date-in-citation>01-10-2024</date-in-citation></element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walters</surname><given-names>DP</given-names></name><name name-style="western"><surname>Gatling</surname><given-names>W</given-names></name><name name-style="western"><surname>Mullee</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hill</surname><given-names>RD</given-names></name></person-group><article-title>The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group</article-title><source>Diabet Med</source><month>05</month><year>1992</year><volume>9</volume><issue>4</issue><fpage>354</fpage><lpage>358</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1111/j.1464-5491.1992.tb01796.x</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">1600707</pub-id></element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>DG</given-names></name><name name-style="western"><surname>Boulton</surname><given-names>AJM</given-names></name><name name-style="western"><surname>Bus</surname><given-names>SA</given-names></name></person-group><article-title>Diabetic foot ulcers and their recurrence</article-title><source>N Engl J Med</source><month>Jun</month><day>15</day><year>2017</year><volume>376</volume><issue>24</issue><fpage>2367</fpage><lpage>2375</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1056/NEJMra1615439</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">28614678</pub-id></element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crawford</surname><given-names>F</given-names></name><name name-style="western"><surname>Nicolson</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Amanna</surname><given-names>AE</given-names></name><etal>et al</etal></person-group><article-title>Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data</article-title><source>Diabetologia</source><month>01</month><year>2020</year><volume>63</volume><issue>1</issue><fpage>49</fpage><lpage>64</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1007/s00125-019-05020-7</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">31773194</pub-id><pub-id pub-id-type="pmcid">PMC6890632</pub-id></element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alahakoon</surname><given-names>C</given-names></name><name name-style="western"><surname>Fernando</surname><given-names>M</given-names></name><name name-style="western"><surname>Galappaththy</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Meta-analyses of randomized controlled trials reporting the effect of home foot temperature monitoring, patient education or offloading footwear on the incidence of diabetes-related foot ulcers</article-title><source>Diabet Med</source><month>Aug</month><year>2020</year><volume>37</volume><issue>8</issue><fpage>1266</fpage><lpage>1279</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1111/dme.14323</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">32426872</pub-id></element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ena</surname><given-names>J</given-names></name><name name-style="western"><surname>Carretero-Gomez</surname><given-names>J</given-names></name><name name-style="western"><surname>Arevalo-Lorido</surname><given-names>JC</given-names></name><name name-style="western"><surname>Sanchez-Ardila</surname><given-names>C</given-names></name><name name-style="western"><surname>Zapatero-Gaviria</surname><given-names>A</given-names></name><name name-style="western"><surname>G&#243;mez-Huelgas</surname><given-names>R</given-names></name></person-group><article-title>The association between elevated foot skin temperature and the incidence of diabetic foot ulcers: a meta-analysis</article-title><source>Int J Low Extrem Wounds</source><month>Jun</month><year>2021</year><volume>20</volume><issue>2</issue><fpage>111</fpage><lpage>118</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1177/1534734619897501</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">32106729</pub-id></element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ara&#250;jo</surname><given-names>AL de</given-names></name><name name-style="western"><surname>Negreiros</surname><given-names>FD da S</given-names></name><name name-style="western"><surname>Flor&#234;ncio</surname><given-names>RS</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>SKP de</given-names></name><name name-style="western"><surname>Silva</surname><given-names>ARV da</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>TMM</given-names></name></person-group><article-title>Efeito da termometria na preven&#231;&#227;o de &#250;lceras de p&#233; diab&#233;tico: revis&#227;o sistem&#225;tica com metan&#225;lise</article-title><source>Rev Latino-Am Enfermagem</source><year>2022</year><volume>30</volume><comment>doi</comment><pub-id pub-id-type="doi">10.1590/1518-8345.5663.3567</pub-id><pub-id pub-id-type="pmcid">PMC9109465</pub-id><pub-id pub-id-type="pmid">35584410</pub-id></element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golledge</surname><given-names>J</given-names></name><name name-style="western"><surname>Fernando</surname><given-names>ME</given-names></name><name name-style="western"><surname>Alahakoon</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Efficacy of at home monitoring of foot temperature for risk reduction of diabetes-related foot ulcer: a meta-analysis</article-title><source>Diabetes Metab Res Rev</source><month>Sep</month><year>2022</year><volume>38</volume><issue>6</issue><elocation-id>e3549</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1002/dmrr.3549</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">35605998</pub-id><pub-id pub-id-type="pmcid">PMC9541448</pub-id></element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavery</surname><given-names>LA</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>KR</given-names></name><name name-style="western"><surname>Lanctot</surname><given-names>DR</given-names></name><etal>et al</etal></person-group><article-title>Home monitoring of foot skin temperatures to prevent ulceration</article-title><source>Diabetes Care</source><month>Nov</month><year>2004</year><volume>27</volume><issue>11</issue><fpage>2642</fpage><lpage>2647</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.2337/diacare.27.11.2642</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">15504999</pub-id></element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavery</surname><given-names>LA</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>KR</given-names></name><name name-style="western"><surname>Lanctot</surname><given-names>DR</given-names></name><etal>et al</etal></person-group><article-title>Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool</article-title><source>Diabetes Care</source><month>01</month><year>2007</year><volume>30</volume><issue>1</issue><fpage>14</fpage><lpage>20</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.2337/dc06-1600</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">17192326</pub-id></element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>DG</given-names></name><name name-style="western"><surname>Holtz-Neiderer</surname><given-names>K</given-names></name><name name-style="western"><surname>Wendel</surname><given-names>C</given-names></name><name name-style="western"><surname>Mohler</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kimbriel</surname><given-names>HR</given-names></name><name name-style="western"><surname>Lavery</surname><given-names>LA</given-names></name></person-group><article-title>Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients</article-title><source>Am J Med</source><month>Dec</month><year>2007</year><volume>120</volume><issue>12</issue><fpage>1042</fpage><lpage>1046</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1016/j.amjmed.2007.06.028</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">18060924</pub-id></element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skafjeld</surname><given-names>A</given-names></name><name name-style="western"><surname>Iversen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Holme</surname><given-names>I</given-names></name><name name-style="western"><surname>Ribu</surname><given-names>L</given-names></name><name name-style="western"><surname>Hvaal</surname><given-names>K</given-names></name><name name-style="western"><surname>Kilhovd</surname><given-names>BK</given-names></name></person-group><article-title>A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes--a randomized controlled trial</article-title><source>BMC Endocr Disord</source><month>Oct</month><day>9</day><year>2015</year><volume>15</volume><elocation-id>55</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1186/s12902-015-0054-x</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">26452544</pub-id><pub-id pub-id-type="pmcid">PMC4600271</pub-id></element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bus</surname><given-names>SA</given-names></name><name name-style="western"><surname>Aan de Stegge</surname><given-names>WB</given-names></name><name name-style="western"><surname>van Baal</surname><given-names>JG</given-names></name><name name-style="western"><surname>Busch-Westbroek</surname><given-names>TE</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name><name name-style="western"><surname>van Netten</surname><given-names>JJ</given-names></name></person-group><article-title>Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP)</article-title><source>BMJ Open Diabetes Res Care</source><month>Sep</month><year>2021</year><volume>9</volume><issue>1</issue><elocation-id>e002392</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1136/bmjdrc-2021-002392</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">34493496</pub-id><pub-id pub-id-type="pmcid">PMC8424833</pub-id></element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bus</surname><given-names>SA</given-names></name><name name-style="western"><surname>Lavery</surname><given-names>LA</given-names></name><name name-style="western"><surname>Monteiro-Soares</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update)</article-title><source>Diabetes Metab Res Rev</source><month>Mar</month><year>2020</year><volume>36 Suppl 1</volume><elocation-id>e3269</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1002/dmrr.3269</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">32176451</pub-id></element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hingorani</surname><given-names>A</given-names></name><name name-style="western"><surname>LaMuraglia</surname><given-names>GM</given-names></name><name name-style="western"><surname>Henke</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine</article-title><source>J Vasc Surg</source><month>Feb</month><year>2016</year><volume>63</volume><issue>2 Suppl</issue><fpage>3S</fpage><lpage>21S</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1016/j.jvs.2015.10.003</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">26804367</pub-id></element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavery</surname><given-names>LA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>KE</given-names></name><name name-style="western"><surname>Berriman</surname><given-names>SJ</given-names></name><etal>et al</etal></person-group><article-title>WHS guidelines update: diabetic foot ulcer treatment guidelines</article-title><source>Wound Repair Regen</source><year>2016</year><volume>24</volume><issue>1</issue><fpage>112</fpage><lpage>126</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1111/wrr.12391</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">26663430</pub-id></element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothenberg</surname><given-names>GM</given-names></name><name name-style="western"><surname>Page</surname><given-names>J</given-names></name><name name-style="western"><surname>Stuck</surname><given-names>R</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>L</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>I</given-names></name></person-group><article-title>Remote temperature monitoring of the diabetic foot: from research to practice</article-title><source>Fed Pract</source><month>Mar</month><year>2020</year><volume>37</volume><issue>3</issue><fpage>114</fpage><lpage>124</lpage><comment>Medline</comment><pub-id pub-id-type="pmid">32317847</pub-id><pub-id pub-id-type="pmcid">PMC7170172</pub-id></element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Najafi</surname><given-names>B</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>ND</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>DG</given-names></name></person-group><article-title>Leveraging smart technologies to improve the management of diabetic foot ulcers and extend ulcer-free days in remission</article-title><source>Diabetes Metab Res Rev</source><month>Mar</month><year>2020</year><volume>36 Suppl 1</volume><elocation-id>e3239</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1002/dmrr.3239</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">31909547</pub-id></element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="webpage"><article-title>How innovation and partnership are ending diabetic limb loss at VA</article-title><source>Department of Veterans Affairs</source><year>2021</year><comment>URL</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://news.va.gov/74980/innovation-partnership-ending-diabetic-limb-loss-va/" ext-link-type="uri">https://news.va.gov/74980/innovation-partnership-ending-diabetic-limb-loss-va/</ext-link><comment>Accessed</comment><date-in-citation>09-10-2024</date-in-citation></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frykberg</surname><given-names>RG</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>IL</given-names></name><name name-style="western"><surname>Reyzelman</surname><given-names>AM</given-names></name><etal>et al</etal></person-group><article-title>Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers</article-title><source>Diabetes Care</source><month>07</month><year>2017</year><volume>40</volume><issue>7</issue><fpage>973</fpage><lpage>980</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.2337/dc16-2294</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">28465454</pub-id></element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>AN</given-names></name><name name-style="western"><surname>Lee</surname><given-names>RE</given-names></name><name name-style="western"><surname>Shambaugh-Miller</surname><given-names>MD</given-names></name><etal>et al</etal></person-group><article-title>Defining &#8220;rural&#8221; for veterans&#8217; health care planning</article-title><source>J Rural Health</source><year>2010</year><volume>26</volume><issue>4</issue><fpage>301</fpage><lpage>309</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1111/j.1748-0361.2010.00298.x</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">21029164</pub-id></element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kind</surname><given-names>AJH</given-names></name><name name-style="western"><surname>Buckingham</surname><given-names>WR</given-names></name></person-group><article-title>Making neighborhood-disadvantage metrics accessible&#8212;the neighborhood atlas</article-title><source>N Engl J Med</source><month>Jun</month><day>28</day><year>2018</year><volume>378</volume><issue>26</issue><fpage>2456</fpage><lpage>2458</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1056/NEJMp1802313</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">29949490</pub-id><pub-id pub-id-type="pmcid">PMC6051533</pub-id></element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gagne</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Glynn</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Avorn</surname><given-names>J</given-names></name><name name-style="western"><surname>Levin</surname><given-names>R</given-names></name><name name-style="western"><surname>Schneeweiss</surname><given-names>S</given-names></name></person-group><article-title>A combined comorbidity score predicted mortality in elderly patients better than existing scores</article-title><source>J Clin Epidemiol</source><month>07</month><year>2011</year><volume>64</volume><issue>7</issue><fpage>749</fpage><lpage>759</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.10.004</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">21208778</pub-id><pub-id pub-id-type="pmcid">PMC3100405</pub-id></element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>XL</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>DB</given-names></name></person-group><article-title>Performing likelihood ratio tests with multiply-imputed data sets</article-title><source>Biometrika</source><year>1992</year><volume>79</volume><issue>1</issue><fpage>103</fpage><lpage>111</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1093/biomet/79.1.103</pub-id></element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Buuren</surname><given-names>S</given-names></name><name name-style="western"><surname>Groothuis-Oudshoorn</surname><given-names>K</given-names></name></person-group><article-title>mice: multivariate imputation by chained equations in R</article-title><source>J Stat Softw</source><year>2011</year><volume>45</volume><fpage>1</fpage><lpage>67</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.18637/jss.v045.i03</pub-id></element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rubin</surname><given-names>D</given-names></name></person-group><source>Multiple Imputation for Nonresponse in Surveys</source><publisher-name>John Wiley &amp; Sons</publisher-name><year>2004</year></element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnard</surname><given-names>J</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>DB</given-names></name></person-group><article-title>Miscellanea. Small-sample degrees of freedom with multiple imputation</article-title><source>Biometrika</source><month>Dec</month><day>1</day><year>1999</year><volume>86</volume><issue>4</issue><fpage>948</fpage><lpage>955</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1093/biomet/86.4.948</pub-id></element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>J</given-names></name><name name-style="western"><surname>Monette</surname><given-names>G</given-names></name></person-group><article-title>Generalized collinearity diagnostics</article-title><source>J Am Stat Assoc</source><month>Mar</month><year>1992</year><volume>87</volume><issue>417</issue><fpage>178</fpage><lpage>183</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1080/01621459.1992.10475190</pub-id></element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrell</surname><given-names>FE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KL</given-names></name><name name-style="western"><surname>Mark</surname><given-names>DB</given-names></name></person-group><article-title>Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors</article-title><source>Stat Med</source><month>Feb</month><day>28</day><year>1996</year><volume>15</volume><issue>4</issue><fpage>361</fpage><lpage>387</lpage><comment>doi</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1097-0258(19960229)15:4&amp;#x0003c;361::AID-SIM168&amp;#x0003e;3.0.CO;2-4</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">8668867</pub-id></element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Lavery</surname><given-names>L</given-names></name><name name-style="western"><surname>Davies</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Webb</surname><given-names>D</given-names></name><name name-style="western"><surname>Rowlands</surname><given-names>AV</given-names></name></person-group><article-title>Hotspots: adherence in home foot temperature monitoring interventions for at-risk feet with diabetes-a narrative review</article-title><source>Diabet Med</source><month>Oct</month><year>2023</year><volume>40</volume><issue>10</issue><elocation-id>e15189</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.1111/dme.15189</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">37489103</pub-id></element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazo-Porras</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernabe-Ortiz</surname><given-names>A</given-names></name><name name-style="western"><surname>Taype-Rondan</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Foot thermometry with mHealth-based supplementation to prevent diabetic foot ulcers: a randomized controlled trial</article-title><source>Wellcome Open Res</source><year>2020</year><volume>5</volume><elocation-id>23</elocation-id><comment>doi</comment><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15531.2</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">32923686</pub-id><pub-id pub-id-type="pmcid">PMC7463300</pub-id></element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiMatteo</surname><given-names>MR</given-names></name></person-group><article-title>Variations in patients&#8217; adherence to medical recommendations: a quantitative review of 50 years of research</article-title><source>Med Care</source><month>Mar</month><year>2004</year><volume>42</volume><issue>3</issue><fpage>200</fpage><lpage>209</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1097/01.mlr.0000114908.90348.f9</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">15076819</pub-id></element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkatesh</surname><given-names>V</given-names></name><name name-style="western"><surname>Thong</surname><given-names>JYL</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Consumer acceptance and use of information technology: extending the Unified Theory of Acceptance and Use of Technology</article-title><source>MIS Q</source><year>2012</year><volume>36</volume><issue>1</issue><fpage>157</fpage><comment>doi</comment><pub-id pub-id-type="doi">10.2307/41410412</pub-id></element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>E</given-names></name></person-group><source>Diffusion of Innovations</source><edition>5th</edition><publisher-name>Free Press</publisher-name><year>2003</year></element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Legris</surname><given-names>P</given-names></name><name name-style="western"><surname>Ingham</surname><given-names>J</given-names></name><name name-style="western"><surname>Collerette</surname><given-names>P</given-names></name></person-group><article-title>Why do people use information technology? A critical review of the technology acceptance model</article-title><source>Inf Manag</source><month>01</month><year>2003</year><volume>40</volume><issue>3</issue><fpage>191</fpage><lpage>204</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1016/S0378-7206(01)00143-4</pub-id></element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexandre</surname><given-names>K</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J</given-names></name><name name-style="western"><surname>Bugnon</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Factors influencing diabetes self-management in adults: an umbrella review of systematic reviews</article-title><source>JBI Evid Synth</source><month>05</month><year>2021</year><volume>19</volume><issue>5</issue><fpage>1003</fpage><lpage>1118</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.11124/JBIES-20-00020</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">33741836</pub-id></element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>TY</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management</article-title><source>Diabetes Metab</source><month>Nov</month><year>2020</year><volume>46</volume><issue>6</issue><fpage>450</fpage><lpage>460</lpage><comment>doi</comment><pub-id pub-id-type="doi">10.1016/j.diabet.2020.04.002</pub-id><comment>Medline</comment><pub-id pub-id-type="pmid">32387700</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>